Botulinnm toxin (BT) has been used in neurology, ophthalmology, otorhinolar
yngology and gastroenterology. Twenty-four patients with oropharyngeal dysp
hagia treated with BT injection into the cricopharyngeal muscle were report
ed, with good results in up to 79% of the patients, Different techniques we
re used to inject BT: percutaneous (guided by electromyography, computed to
mography or videofluoroscopy) or direct injection during esophagoscopy (wit
h a rigid esophagoscope), We report the first case of oropharyngeal dysphag
ia treated by BT injection into the cricopharyngeal muscle using a flexible
scope, with clinical, radiological and manometric improvement.
A reduction in the disability score 4 to 2 and sustained capacity to mainta
in adequate oral caloric intake were observed. The patient was also able to
have the tracheotomy orifice closed and the gastrostomy tube removed after
3 months, Manometry showed a 38% reduction in the upper esophageal sphinct
er pressure with the presence of pharyngeal waves that were previously abse
nt. After 1 year of follow-up, the patient was in good condition with mild
dysphagia for solid foods. This is another case of complex dysphagia and re
lative hyperfunction of the cricopharyngeal muscle successfully treated wit
h BT injection.